Yingwei Zhen

473 total citations
19 papers, 337 citations indexed

About

Yingwei Zhen is a scholar working on Molecular Biology, Cancer Research and Neurology. According to data from OpenAlex, Yingwei Zhen has authored 19 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Cancer Research and 5 papers in Neurology. Recurrent topics in Yingwei Zhen's work include Cancer-related molecular mechanisms research (5 papers), RNA modifications and cancer (4 papers) and Glioma Diagnosis and Treatment (3 papers). Yingwei Zhen is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), RNA modifications and cancer (4 papers) and Glioma Diagnosis and Treatment (3 papers). Yingwei Zhen collaborates with scholars based in China. Yingwei Zhen's co-authors include Anran Wang, Nan Yang, Lei Han, Cheng Wei, Xiefu Zhang, Xiangyu Zheng, Yue Zhong, Kai Yu, Qiang Huang and Zhiqiang Zhu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Life Sciences.

In The Last Decade

Yingwei Zhen

19 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yingwei Zhen China 10 218 145 52 34 32 19 337
Jianglong Lu China 12 179 0.8× 86 0.6× 50 1.0× 17 0.5× 37 1.2× 27 311
Hua Guo China 13 304 1.4× 185 1.3× 59 1.1× 28 0.8× 48 1.5× 21 448
Peipei Gong China 12 217 1.0× 110 0.8× 57 1.1× 46 1.4× 50 1.6× 31 411
Gabriel N. Valbuena United Kingdom 11 219 1.0× 132 0.9× 39 0.8× 77 2.3× 38 1.2× 13 374
Guifang Xie China 7 220 1.0× 140 1.0× 93 1.8× 13 0.4× 53 1.7× 8 337
Rajendra P. Pangeni United States 13 357 1.6× 138 1.0× 31 0.6× 31 0.9× 91 2.8× 17 484
Karrie Mei Yee Kiang Hong Kong 9 199 0.9× 159 1.1× 32 0.6× 28 0.8× 17 0.5× 17 307
Ratnakar Patti United States 10 216 1.0× 74 0.5× 31 0.6× 42 1.2× 86 2.7× 10 366
Lu Kong China 12 292 1.3× 87 0.6× 30 0.6× 10 0.3× 70 2.2× 33 462

Countries citing papers authored by Yingwei Zhen

Since Specialization
Citations

This map shows the geographic impact of Yingwei Zhen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingwei Zhen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingwei Zhen more than expected).

Fields of papers citing papers by Yingwei Zhen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingwei Zhen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingwei Zhen. The network helps show where Yingwei Zhen may publish in the future.

Co-authorship network of co-authors of Yingwei Zhen

This figure shows the co-authorship network connecting the top 25 collaborators of Yingwei Zhen. A scholar is included among the top collaborators of Yingwei Zhen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingwei Zhen. Yingwei Zhen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Wang, Bo, Xiaoyang Zhang, Ze‐Sheng Li, et al.. (2024). Polo-like kinase 4 promotes tumorigenesis and glucose metabolism in glioma by activating AKT1 signaling. Cancer Letters. 585. 216665–216665. 5 indexed citations
2.
Wang, Bo, et al.. (2024). Polo-like kinase 4 accelerates glioma malignant progression and vasculogenic mimicry by phosphorylating EphA2. Cancer Letters. 611. 217397–217397. 4 indexed citations
3.
Luo, Lin, Yingwei Zhen, Cheng Wei, et al.. (2022). The role of N6-methyladenosine-modified non-coding RNAs in the pathological process of human cancer. Cell Death Discovery. 8(1). 325–325. 15 indexed citations
4.
Luo, Lin, Xiaoyang Zhang, Yingwei Zhen, et al.. (2022). Polo-like kinase 1 is related with malignant characteristics and inhibits macrophages infiltration in glioma. Frontiers in Immunology. 13. 1058036–1058036. 5 indexed citations
5.
Zhang, Qian, et al.. (2022). Circular RNA circFGFR1 Functions as an Oncogene in Glioblastoma Cells through Sponging to hsa-miR-224-5p. Journal of Immunology Research. 2022. 1–14. 9 indexed citations
6.
Gao, Peng, Xuqiang Zhu, Yingwei Zhen, et al.. (2021). A Clinical Prognostic Model Based on Preoperative Hematological and Clinical Parameters Predicts the Progression of Primary WHO Grade II Meningioma. Frontiers in Oncology. 11. 748586–748586. 7 indexed citations
7.
Gao, Peng, Di Chen, Dongtao Zhang, et al.. (2021). Follow-up outcomes of different bypass surgical modalities for adults with ischaemic-type moyamoya disease. British Journal of Neurosurgery. 37(2). 148–157. 4 indexed citations
8.
Yang, Nan, Yingwei Zhen, Le Wang, et al.. (2021). miRNA-451 regulates the NF-κB signaling pathway by targeting IKKβ to inhibit glioma cell growth. Cell Cycle. 20(19). 1967–1977. 11 indexed citations
9.
Shen, Lin, Yingwei Zhen, Y. Guan, & Haimang Yi. (2020). Roles of Wnt/β-Catenin Signaling Pathway Regulatory Long Non-Coding RNAs in the Pathogenesis of Non-Small Cell Lung Cancer. SHILAP Revista de lepidopterología. 1 indexed citations
10.
Li, Xueyuan, Guohui Huang, Qiankun Liu, et al.. (2020). Porf-2 Inhibits Tumor Cell Migration Through the MMP-2/9 Signaling Pathway in Neuroblastoma and Glioma. Frontiers in Oncology. 10. 975–975. 10 indexed citations
11.
Wei, Cheng, et al.. (2020). Recent advances in unraveling the molecular mechanisms and functions of HOXA11‑AS in human cancers and other diseases (Review). Oncology Reports. 43(6). 1737–1754. 22 indexed citations
12.
Zhen, Yingwei, et al.. (2019). Cinnamic acid rescues behavioral deficits in a mouse model of traumatic brain injury by targeting miR-455-3p/HDAC2. Life Sciences. 235. 116819–116819. 33 indexed citations
13.
Wang, Zengguang, Kai Huang, Yanwei Liu, et al.. (2018). PLK4 is a determinant of temozolomide sensitivity through phosphorylation of IKBKE in glioblastoma. Cancer Letters. 443. 91–107. 47 indexed citations
14.
Zhen, Yingwei, et al.. (2018). Design, synthesis and antiproliferative evaluation of novel sulfanilamide-1,2,3-triazole derivatives as tubulin polymerization inhibitors. Investigational New Drugs. 36(6). 1147–1157. 8 indexed citations
15.
Zhen, Yingwei, et al.. (2018). Knockdown of NEAT1 repressed the malignant progression of glioma through sponging miR‐107 and inhibiting CDK14. Journal of Cellular Physiology. 234(7). 10671–10679. 35 indexed citations
16.
Zhen, Yingwei, et al.. (2017). Transplantation of bone mesenchymal stem cells promotes angiogenesis and improves neurological function after traumatic brain injury in mouse. Neuropsychiatric Disease and Treatment. Volume 13. 2757–2765. 41 indexed citations
17.
Zhen, Yingwei, et al.. (2017). Geranylgeranylacetone exerts neuroprotective roles through medicating the phosphatidylinositol-3 kinase/Akt signaling pathway in an intracerebral hemorrhage rat model. International Journal of Neuroscience. 128(10). 893–898. 3 indexed citations
18.
Yang, Nan, Yingwei Zhen, Yahui Zhang, et al.. (2016). miRNA-451 inhibits glioma cell proliferation and invasion by downregulating glucose transporter 1. Tumor Biology. 37(10). 13751–13761. 51 indexed citations
19.
Zhen, Yingwei, et al.. (2014). Knockdown of EGFR inhibits growth and invasion of gastric cancer cells. Cancer Gene Therapy. 21(11). 491–497. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jianglong Lu Breakdown of academic impact, for papers by Hua Guo Breakdown of academic impact, for papers by Peipei Gong Breakdown of academic impact, for papers by Gabriel N. Valbuena Breakdown of academic impact, for papers by Guifang Xie Breakdown of academic impact, for papers by Rajendra P. Pangeni Breakdown of academic impact, for papers by Karrie Mei Yee Kiang Breakdown of academic impact, for papers by Ratnakar Patti Breakdown of academic impact, for papers by Lu Kong
Rankless by CCL
2026